Estrella ImmunopharmaESLA
13F holders, Q3 2025 (September 30)At the end of Q3 2025, 13 institutions reported holding Estrella Immunopharma Inc. (ESLA) in their 13F filings, up 2 from Q2 2025. 3 opened new positions and 1 sold out. The largest holders were Vanguard Group Inc. ($499K), Geode Capital Management, LLC ($121K) and Citadel Advisors ($60K). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Estrella Immunopharma Inc.
- CUSIP
- 297584104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $25K |
| Exits | 1 | $14K |
All 13F filers, Q2 2025 → Q3 2025: 157,931 shares bought and 49,564 shares sold, net +108,367 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 13 holders
| Vanguard Group Inc. | 0.00% | Add +48.4% | 419,711 | $499K |
| Geode Capital Management, LLC | 0.00% | Reduce -1.8% | 101,490 | $121K |
| Citadel Advisors | 0.00% | Reduce -0.1% | 50,122 | $60K |
| UBS Group AG | 0.00% | Reduce -30.8% | 50,347 | $58K |
| Atw Spac Management LLC | 0.06% | No change | 40,000 | $46K |
| BlackRock, Inc. | 0.00% | Reduce -23.3% | 24,084 | $28K |
| State Street Corp. | 0.00% | No change | 22,352 | $27K |
| XTX Topco Ltd | 0.00% | New | 10,373 | $12K |
| Renaissance Technologies | 0.00% | New | 10,689 | $12K |
| MASO CAPITAL PARTNERS Ltd | 0.02% | No change | 10,000 | $12K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -12.6% | 4,015 | $5K |
| Bank of America Corp. | 0.00% | Reduce -97.8% | 2 | $2 |
| SBI Securities Co., Ltd. | 0.00% | New | 1 | $1 |
"% of holder's portfolio" is ESLA's weight in each manager's 13F, not the share of Estrella Immunopharma Inc. the manager owns.